on a mobile?
vTap
    Loading...
 
suggest
Daiichi Sankyo Co.
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daiichi Sankyo Co.
Go to Feed to see what's new!
+Feed
 
Wikipedia.org
Daiichi Sankyo Co. (Wikipedia.org)

Daiichi Sankyo Company Limited ( ) is a joint holding company established in 2005 by Sankyo Co., Ltd. and Daiichi Pharmaceutical Co., Ltd., which are pharmaceutical companies based in Japan. Its main offices are located in Chūō-ku, Tokyo.

more...
Videos
Refine
Ranbaxy-Daiichi Sankyo is still good despite the co's trouble with US laws.
a year ago
CNN-IBN (India)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daiichi Sankyo Co.
Ranbaxy Laboratories
Food and Drug Administration
Go to Feed to see what's new!
share
keep
 
 
Jul 16 - Ranbaxy Laboratories Ltd's deal for a takeover by Japan's Daiichi Sankyo remains on track and the Indian firm will give U.S. authorities all information needed for a probe within the next ...
1m 7s |
a year ago
Reuters
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Daiichi Sankyo Co.
United States
Go to Feed to see what's new!
share
keep
 
 
Malvinder Singh says Daiichi Sankyo was aware of the US FDA issue before the deal was signed.
a year ago
CNN-IBN (India)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daiichi Sankyo Co.
Go to Feed to see what's new!
share
keep
 
 
13005
Sharmila Joshi of Prabhudas Lilladher is of the view that Ranbaxy is looking good at current level. On the operation front Daiichi Sankyo should be able to leverage Ranbaxy acquisition and increase ...
a year ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daiichi Sankyo Co.
Sharmila Tagore
Go to Feed to see what's new!
share
keep
 
 
13530
Malvinder Singh, MD and CEO, Ranbaxy Laboratories, said Daiichi Sankyo would get 50.1% stake in Ranbaxy. "Ranbaxy will turn into a debt free company post deal. About USD 440 million FCCBs will be ...
a year ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Daiichi Sankyo Co.
Go to Feed to see what's new!
share
keep
 
 
Nov. 20 - Japanese drugmaker Daiichi Sankyo says it's in the last stages of getting approval for its blood clot prevention drug Prasugrel from the U.S. Food & Drug Administration. US CEO Joe Peroni, ...
3m 50s |
a year ago
Reuters
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
United States
Prasugrel
United States Department of Health and Human Services
Daiichi Sankyo Co.
Dietary supplement
Drug abuse
Medical device
Go to Feed to see what's new!
share
keep
 
 
Ranbaxy will probably accept Daiichi Sankyo's buyout offer, predicts Aadil Ebrahim, investment manager at Bowen Capital Management. He revie...
4m 12s |
a year ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Investment management
Don Revie
Daiichi Sankyo Co.
Go to Feed to see what's new!
share
keep
 
 
Rhenu Bhuller, pharmaceutical analyst at Frost & Sullivan, talks with Bloomberg's Bernard Lo from Singapore about Daiichi Sankyo Co.'s purchase of Ranbaxy Laboratories Ltd., the role of generic ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Daiichi Sankyo Co.
Pharmaceutical company
Drug development
Theta role
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums Send Feedback
Privacy Policy and Terms of Use